4Zhong RZ, Andrew I, Lazarovits AI. Monoclonal antibody against CD45RB for the therapy of rejection and autoimmune diseases[J]. Mol Md, 1998, 76: 572-580.
5Becher B, Barker PA, Owens T, et al. CD95-CD95L: can the brain learn from the immune system[J]. Trends Neurosci, 1998, 21:114-117.
7Wing K, Sakaguchi S. Regulatory T cells as potential immunotherapy in allergy [J].Curr Opin Allergy Clin Immunol, 2006, 6: 482-488.
8Williams LM, Rudensky AY. Maintenance of the Foxp32 dependent developmental program in mature regulatory T cells requires continued expression of Foxp3 [J].Nat Immunol, 2007, 8: 277-284.
9kasprewiez DJ. Smallwood PS, Tyznik AJ, et al. Scurfin (FOXP3) controls T-dependent immune responses in vivo through regulation of CD4T cell effector function [J]. Immunol, 2003, 17: 1216-1223.
10Schecter A, Birnbaum L, Ryan JJ, et al. Constable dioxins: an overview [J]. Environmental Research, 2006, 101: 419- 428.
